1. Home
  2. DERM vs ORGO Comparison

DERM vs ORGO Comparison

Compare DERM & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$6.15

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$1.40

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
ORGO
Founded
2014
1985
Country
United States
United States
Employees
N/A
854
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
181.4M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
DERM
ORGO
Price
$6.15
$1.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
★ $12.67
$8.50
AVG Volume (30 Days)
156.5K
★ 594.1K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
34.72
★ 1600.00
EPS
★ N/A
N/A
Revenue
$61,858,000.00
★ $564,169,000.00
Revenue This Year
$39.72
N/A
Revenue Next Year
$63.24
$26.27
P/E Ratio
★ N/A
N/A
Revenue Growth
10.20
★ 17.04
52 Week Low
$4.31
$1.34
52 Week High
$9.56
$7.08

Technical Indicators

Market Signals
Indicator
DERM
ORGO
Relative Strength Index (RSI) 32.17 33.35
Support Level $5.92 $1.34
Resistance Level $6.59 $2.69
Average True Range (ATR) 0.43 0.07
MACD -0.17 0.01
Stochastic Oscillator 0.53 17.65

Price Performance

Historical Comparison
DERM
ORGO

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: